about
The German National Program on Psoriasis Health Care 2005-2015: results and experiencesApremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic diseaseThe impact of age on psoriasis health care in Germany.Facing the dilemma of patient-centred psoriasis care: a qualitative study identifying patient needs in dermatological outpatient clinics.Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis.Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex.Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: Results of the randomized, double-blind, Phase 3 NAVIGATE trial.Measuring the burden of treatment for chronic disease: implications of a scoping review of the literatureEfficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies.Patient-centred health care for people with chronic skin conditions.Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study.Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention.Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.Measuring the importance of health domains in psoriasis - discrete choice experiment versus rating scales.Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
P2860
Q26751448-DA8B1A64-A45B-48C7-B886-FCA2BF9D1BDCQ37505449-3FFAC534-CD66-4F83-8CA2-188F89B2E47BQ39024781-19952834-4934-4F6E-867C-7FFB637C1EEFQ39053859-9D9FB146-F9AE-47AF-935A-6DF8ADFC56AEQ39164271-15EF4D13-A2F6-481E-BD31-95E41DECA932Q39537824-D1CAEAC3-C060-423E-8B37-A9DA6AC632A1Q40164172-FB910A6F-E329-4EC1-A16B-FC10C3469464Q41172036-BCE2DEE0-A1B9-4513-ABDD-2C31E5F896CFQ47937410-3CA52531-E3E8-41F8-BD76-793F384659BDQ48194703-DCC771A4-BCD6-4C83-86F2-641B5BCEF890Q48295756-CB9CFF2C-C139-4916-A9C6-48ECF77BE074Q50130587-4E98E390-585F-4A7D-B947-BF5AB89C06B1Q53123754-0F6BFD22-5DA8-4BFF-AA80-1FE7FBD315ACQ55129690-A4DA4706-67AF-408B-A74D-C3F2D40B25D4Q57816525-67C2DB20-3D5C-459C-9706-D99E2E7D2F39
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Patient-relevant treatment goals in psoriasis.
@en
Patient-relevant treatment goals in psoriasis.
@nl
type
label
Patient-relevant treatment goals in psoriasis.
@en
Patient-relevant treatment goals in psoriasis.
@nl
prefLabel
Patient-relevant treatment goals in psoriasis.
@en
Patient-relevant treatment goals in psoriasis.
@nl
P2093
P2860
P1476
Patient-relevant treatment goals in psoriasis.
@en
P2093
Christina Spehr
Christine Blome
Diamant Thaçi
Kristian Reich
Marc A Radtke
Matthias Augustin
Ramona Gosau
Stephan J Rustenbach
P2860
P2888
P356
10.1007/S00403-015-1613-8
P577
2015-12-19T00:00:00Z